Radiosurgery/Radiation therapy
Cancer: Mevion Medical lands $55M to deploy proton therapy system
Massachusetts-based Mevion Medical secured $55 million in funding in support of accelerated deployment of the company’s single-room-proton therapy systems, a smaller, cheaper radiation therapy system for targeting cancerous tumors.
Mevion reported that it raised the funds from existing equity investors Caxton Heath Life Sciences, ProQuest Investments, Venrock, and CHL Medical Partners, as well as through debt financing provided by Life Sciences Alternative Funding.
Accuray touts new order volume amid sinking sales, widening losses in Q3
Varian slides amid uncertainty in U.S. and E.U. oncology markets
Varian Medical Systems (NYSE:VAR) was none too pleased with the market for its oncology systems, calling its Q2 revenues for that division "disappointing, particularly in the U.S."
Recall: Accuray explains caution on CyberKnife radiosurgery system
Elekta lands FDA win for next-generation linear accelerator
J&J mesh lawsuit penalty grows to $11.1M | MassDevice.com On Call
MASSDEVICE ON CALL — A jury hiked up penalties against Johnson & Johnson (NYSE:JNJ) and its subsidiary Ethicon to more than $11 million after finding the companies liable in a patient injury lawsuit against the companies’ transvaginal mesh implants.
BRIC: Varian taps “brain power” in Russia
Radiotherapy devices maker Varian Medical Systems (NYSE:VAR) announced a collaborative research & development initiative designed to "tap brain power" among Russia’s scientific institutes.
Women’s health: Halt Medical lands Mexican win for uterine fibroid treatment
Women’s health devices maker Halt Medical touted a win from Mexican healthcare regulators who granted registration for the Acessa System for treating uterine fibroids.
The Acessa technology represents a major shift in treatment of uterine fibroids, the company has said. Fibroids are the leading global cause of hysterectomy procedures, according to the Centers for Disease Control & Prevention.
Holaira raises $10M for lung device | Wall Street Beat
Medical device company Holaira said it drummed up $10 million, changed its name and moved its headquarters.
Formerly known as Innovative Pulmonary Solutions, Holaira said it plans to use the Series C round to develop its minimally invasive devices to treat obstructive lung disease. All of Holaira’s existing backers participated, namely Advanced Technology Ventures, Morgenthaler Ventures, Split Rock Partners, and Versant Ventures.
Cancer: Sarif Biomedical sues Accuray over CyberKnife
Sarif Biomedical accused Accuray (NSDQ:ARAY) of infringing 1 of its patents with the CyberKnife radiosurgery device for cancer, which uses targeted radiation blasts to destroy tumor cells.
Tool, Texas-based Sarif’s patent covers ""Computer-Assisted Microsurgery Methods and Equipment." The medical device company alleges that Accuray’s device trespasses on that intellectual property, according to the lawsuit.